MML Investors Services LLC Sells 53,465 Shares of Haleon plc (NYSE:HLN)

MML Investors Services LLC cut its holdings in shares of Haleon plc (NYSE:HLN) by 15.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 292,782 shares of the company’s stock after selling 53,465 shares during the period. MML Investors Services LLC’s holdings in Haleon were worth $3,098,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. FMR LLC lifted its holdings in Haleon by 5.8% during the third quarter. FMR LLC now owns 104,918,269 shares of the company’s stock worth $1,110,035,000 after acquiring an additional 5,768,117 shares in the last quarter. Clearbridge Investments LLC lifted its holdings in Haleon by 8.6% during the second quarter. Clearbridge Investments LLC now owns 41,753,987 shares of the company’s stock worth $344,888,000 after acquiring an additional 3,307,009 shares in the last quarter. Wellington Management Group LLP lifted its holdings in Haleon by 49.9% during the third quarter. Wellington Management Group LLP now owns 9,152,490 shares of the company’s stock worth $96,833,000 after acquiring an additional 3,046,841 shares in the last quarter. Sculptor Capital LP raised its stake in shares of Haleon by 67.8% in the 2nd quarter. Sculptor Capital LP now owns 8,887,098 shares of the company’s stock valued at $73,407,000 after purchasing an additional 3,592,000 shares during the period. Finally, Envestnet Asset Management Inc. raised its stake in shares of Haleon by 2.7% in the 2nd quarter. Envestnet Asset Management Inc. now owns 7,572,548 shares of the company’s stock valued at $62,549,000 after purchasing an additional 196,843 shares during the period. 6.67% of the stock is currently owned by institutional investors.

Haleon Price Performance

NYSE:HLN opened at $9.76 on Friday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. The stock’s 50-day simple moving average is $9.75 and its 200 day simple moving average is $9.52. The company has a market cap of $44.18 billion, a P/E ratio of 28.71, a P/E/G ratio of 2.95 and a beta of 0.28. Haleon plc has a 52-week low of $7.89 and a 52-week high of $10.80.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on HLN shares. UBS Group raised Haleon to a “strong-buy” rating in a research note on Tuesday, October 1st. Morgan Stanley lifted their price target on Haleon from $9.90 to $10.95 and gave the company an “overweight” rating in a research note on Friday, September 20th. One analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Buy” and an average target price of $10.95.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.